Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation

被引：33
作者：
El-Salamouni, Noha S. [1 ]
Farid, Ragwa M. [1 ,2 ]
El-Kamel, Amal H. [2 ]
El-Gamal, Safaa S. [2 ]
机构：
[1] Pharos Univ Alexandria, Dept Pharmaceut, Fac Pharm & Drug Mfg, Alexandria, Egypt
[2] Alexandria Univ, Dept Pharmaceut, Fac Pharm, Alexandria, Egypt
来源：
JOURNAL OF MICROENCAPSULATION | 2018年 / 35卷 / 01期
关键词：
Glaucoma; nanostructured lipid carriers; solid lipid nanoparticles; ocular targeting; ocular histology; brimonidine; OCULAR DRUG-DELIVERY; NANOPARTICLES SLN; CAPRA-HIRCUS; PART II; DESIGN; EYE; MATRICES; RELEASE; SYSTEM; GATIFLOXACIN;
D O I：
10.1080/02652048.2018.1425753
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
Brimonidine ocular hypotensive effect can be enhanced by increasing residence time and corneal penetration. The current work aimed to formulate, evaluate and compare nanostructured lipid carriers (NLCs) to solid lipid nanoparticles (SLNs) and commercial eye drops for controlled brimonidine delivery. NLCs prepared by modified high shear homogenisation were spherical with a mean size of 151.97 +/- 1.98nm, negative zeta potential (ZP) of -44.2 +/- 7.81mV, % entrapment efficiency (EE) of 83.631 +/- 0.495% and low crystallinity index (CI) (17.12%), indicating a better drug incorporation. Moreover, they kept stable during storage at 4 degrees C for 3months. Permeability coefficient of NLCs was 1.227 folds higher than that of SLNs. Histological examination revealed localisation of NLCs in the anterior ocular chamber. NLCs revealed the most sustained and highest intraocular pressure (IOP) lowering activity (-13.14 +/- 1.28mmHg) in rabbits. In conclusion, NLCs is a promising approach for IOP reduction compared to eye drops and SLNs.
引用
收藏
页码：102 / 113
页数：12
相关论文
共 44 条
[1]   Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration [J].
Abrego, Guadalupe ;
Alvarado, Helen ;
Souto, Eliana B. ;
Guevara, Bessy ;
Halbaut Bellowa, Lyda ;
Parra, Alexander ;
Calpena, Ana ;
Luisa Garcia, Maria .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 95 :261-270
[2]   Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin [J].
Abul Kalam, Mohd. ;
Sultana, Yasmin ;
Ali, Asgar ;
Aqil, Mohd. ;
Mishra, Anil K. ;
Aljuffali, Ibrahim A. ;
Alshamsan, Aws .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2013, 101 (06) :1813-1827
[3]   Part II: Enhancement of transcorneal delivery of gatifloxacin by solid lipid nanoparticles in comparison to commercial aqueous eye drops [J].
Abul Kalam, Mohd. ;
Sultana, Yasmin ;
Ali, Asgar ;
Aqil, Mohd. ;
Mishra, Anil K. ;
Chuttani, Krishna ;
Aljuffali, Ibrahim A. ;
Alshamsan, Aws .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2013, 101 (06) :1828-1836
[4]   Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges [J].
Almeida, Hugo ;
Amaral, Maria Helena ;
Lobao, Paulo ;
Frigerio, Christian ;
Sousa Lobo, Jose Manuel .
CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (36) :5212-5224
[5]  
[Anonymous], 2003, CHEMICA
[6]   Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye [J].
Araujo, Joana ;
Nikolic, Sasha ;
Egea, Maria A. ;
Souto, Eliana B. ;
Garcia, Maria L. .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 88 (01) :150-157
[7]   Novel physically structured lipid matrices of beeswax and a homolipid from Capra hircus (goat fat):: a physicochemical characterization for application in drug delivery [J].
Attama, A. A. ;
Schicke, B. C. ;
Mueller-Goymann, C. C. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2007, 17 (02) :103-112
[8]   A critical study of novel physically structured lipid matrices composed of a homolipid from Capra hircus and theobroma oil [J].
Attama, A. A. ;
Mueller-Goymann, C. C. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 322 (1-2) :67-78
[9]   Diclofenac sodium delivery to the eye:: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct [J].
Attama, Anthony A. ;
Reichl, Stephan ;
Mueller-Goymann, Christel C. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 355 (1-2) :307-313
[10]   Application of lipid nanoparticles to ocular drug delivery [J].
Battaglia, Luigi ;
Serpe, Loredana ;
Foglietta, Federica ;
Muntoni, Elisabetta ;
Gallarate, Marina ;
Del Pozo Rodriguez, Ana ;
Angeles Solinis, Maria .
EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (12) :1743-1757
12345